메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 31, Issue 6, 2013, Pages 820-821
What is better for older patients with acute myeloid leukemia?
Author keywords

[No Author keywords available]
Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CYTARABINE;
EID: 84875734905     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.2219     Document Type: Letter
Times cited : (4)
References (9)
  • 1
    • 84864063679 scopus 로고    scopus 로고
    • Multicenter, randomized, open-label, phase iii trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
    • Kantarjian HM, Thomas XG, Dmoszynska A, et al: Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol 30:2670- 2677, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 2670-2677
    • Kantarjian, H.M.1    Thomas, X.G.2    Dmoszynska, A.3
  • 2
    • 79951535539 scopus 로고    scopus 로고
    • Acute myeloid leukaemia in the elderly: A review
    • Pollyea DA, Kohrt HE, Medeiros BC: Acute myeloid leukaemia in the elderly: A review. Br J Haematol 152:524-542, 2011
    • (2011) Br J Haematol , vol.152 , pp. 524-542
    • Pollyea, D.A.1    Kohrt, H.E.2    Medeiros, B.C.3
  • 3
    • 79953702269 scopus 로고    scopus 로고
    • Treatment of unfit patients with acute myeloid leukemia: A still open clinical challenge
    • Ferrara F: Treatment of unfit patients with acute myeloid leukemia: A still open clinical challenge. Clin Lymphoma Myeloma Leuk 11:10-16, 2011
    • (2011) Clin Lymphoma Myeloma Leuk , vol.11 , pp. 10-16
    • Ferrara, F.1
  • 4
    • 33947205565 scopus 로고    scopus 로고
    • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
    • DOI 10.1002/cncr.22496
    • Burnett AK, Milligan D, Prentice AG, et al: A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer 109:1114-1124, 2007 (Pubitemid 46435390)
    • (2007) Cancer , vol.109 , Issue.6 , pp. 1114-1124
    • Burnett, A.K.1    Milligan, D.2    Prentice, A.G.3    Goldstone, A.H.4    McMullin, M.F.5    Hills, R.K.6    Wheatley, K.7
  • 5
    • 77449149373 scopus 로고    scopus 로고
    • Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
    • Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al: Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. J Clin Oncol 28:562-569, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 562-569
    • Fenaux, P.1    Mufti, G.J.2    Hellstrom-Lindberg, E.3
  • 6
    • 80051941829 scopus 로고    scopus 로고
    • Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patients?
    • Ferrara F, Musto P: Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patientsCancer 117:3879-3881, 2011
    • (2011) Cancer , vol.117 , pp. 3879-3881
    • Ferrara, F.1    Musto, P.2
  • 7
    • 84857747740 scopus 로고    scopus 로고
    • A multicenter phase ii trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
    • Lubbert M, Ruter BH, Claus R, et al: A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica 97:393-340, 2012
    • (2012) Haematologica , vol.97 , pp. 393-340
    • LuBbert, M.1    RuTer, B.H.2    Claus, R.3
  • 8
    • 84856802139 scopus 로고    scopus 로고
    • Azacitidine for the treatment of patients with acute myeloid leukemia: Report of 82 patients enrolled in an italian compassionate program
    • Maurillo L, Venditti A, Spagnoli A, et al: Azacitidine for the treatment of patients with acute myeloid leukemia: Report of 82 patients enrolled in an Italian Compassionate Program. Cancer 118:1014-1022, 2012
    • (2012) Cancer , vol.118 , pp. 1014-1022
    • Maurillo, L.1    Venditti, A.2    Spagnoli, A.3
  • 9
    • 78650178860 scopus 로고    scopus 로고
    • Treatment of older patients with acute myeloid leukaemia
    • Ferrara F: Treatment of older patients with acute myeloid leukaemia. Lancet 376:1967-1968, 2010
    • (2010) Lancet , vol.376 , pp. 1967-1968
    • Ferrara, F.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.